Clinical Application of Compound Polyethylene Glycol Electrolyte Powder Combined with Linalotide in Colonoscopy Intestinal Preparation

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400088185

Enrollment

Unknown

Registered

2024-08-13

Start date

2024-09-16

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy intestinal preparation status

Interventions

Group A:2L polyethylene glycol electrolyte powder+2 capsules of linalopide

Group B:2L polyethylene glycol electrolyte dispersion

Group C:3L polyethylene glycol electrolyte dispersion

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 18-75 year old patients undergoing colonoscopy

Exclusion criteria

Exclusion criteria: 1. Cecal intubation failed; 2. Have a history of colorectal surgery; 3.Inflammatory bowel disease or intestinal tuberculosis; 4.Pregnant or lactating women; 5.Patients who have undergone colon examination within the past three months; 6.Patients who have taken laxatives or gastrointestinal motility drugs in the past 2 weeks; 7.Refusal to sign informed consent form.

Design outcomes

Primary

Measure	Time frame
Qualification rate of intestinal preparation for each group of patients;	—

Secondary

Measure	Time frame
Detection rate of colorectal adenomas or polyps; Patient's willingness rate to repeat bowel preparation plan;Events related to poor bowel preparation;	—

Countries

China

Contacts

Public ContactWu Zhangxuan

Third People's Hospital of Jingdezhen

1510150986@qq.com+86 187 2048 6084

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026